MAXCYTE, INC. Annual Net Income (Loss) Attributable to Parent in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Maxcyte, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2019 to 2023.
  • Maxcyte, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$9.38M, a 10.8% increase year-over-year.
  • Maxcyte, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$35.4M, a 8.56% decline year-over-year.
  • Maxcyte, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$37.9M, a 60.9% decline from 2022.
  • Maxcyte, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$23.6M, a 23.5% decline from 2021.
  • Maxcyte, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$19.1M, a 61.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$37.9M -$14.4M -60.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 -$23.6M -$4.49M -23.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 -$19.1M -$7.27M -61.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 -$11.8M +$1.08M +8.36% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-22
2019 -$12.9M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.